Literature DB >> 1775196

Apparent heterogeneity of cardiac A1 adenosine receptors as revealed by radioligand binding experiments on N-ethylmaleimide-treated membranes.

E Leung1, K A Jacobson, R D Green.   

Abstract

While G protein-coupled receptors are often studied by analyzing antagonist radioligand: "cold" agonist inhibition curves using an independent site model, it is now clear that KL and KH values determined in these analyses are not reliable estimates of the affinities of the agonists for "free" and G protein-coupled forms of the receptor. Thus, such experiments cannot be used to contrast the characteristics of a given type of receptor in different tissues, i.e., to probe for the existence of receptor subtypes. Since treatment with N-ethylmaleimide treatment blocks receptor: Gi/Go protein interactions, such analyses on N-ethylmaleimide-pretreated membranes should allow direct assessment of the affinities of competing ligands for the free receptor or for multiple receptor subtypes. As A1 adenosine receptors couple to Gi, and perhaps to Go, we have performed A1 adenosine receptor radioligand "competition" studies first on control, then on N-ethylmaleimide-pretreated bovine cardiac and cerebral cortical membranes. Results of experiments with the antagonist radioligand [3H]xanthine amine congener appeared to be confounded by ligand binding to A2 adenosine receptors present in the cardiac membrane preparations. Further experiments utilized the A1-specific radioligand [3H]1,3-dipropyl-8-cyclopentylxanthine. These experiments confirmed once more that the KL values determined by computer analysis of "competition" curves performed on control membranes are not reliable estimates of the affinities of the competing ligand for free receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775196      PMCID: PMC5870127          DOI: 10.1007/BF00174747

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  [(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.

Authors:  X D Ji; G L Stiles; K A Jacobson
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

2.  A1 adenosine receptor of rat testis membranes. Purification and partial characterization.

Authors:  H Nakata
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

3.  Characterization of the K(+)-channel-coupled adenosine receptor in guinea pig atria.

Authors:  H Tawfik-Schlieper; K N Klotz; V A Kreye; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

4.  Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.

Authors:  B T Liang
Journal:  J Pharmacol Exp Ther       Date:  1989-06       Impact factor: 4.030

5.  Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide.

Authors:  S M Yeung; R D Green
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

6.  Uncoupling of gamma-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins.

Authors:  T Asano; N Ogasawara
Journal:  Mol Pharmacol       Date:  1986-03       Impact factor: 4.436

7.  Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.

Authors:  E Leung; R D Green
Journal:  Mol Pharmacol       Date:  1989-09       Impact factor: 4.436

8.  Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.

Authors:  M J Lohse; V Lenschow; U Schwabe
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

9.  Phosphorylation of purified bovine cardiac sarcolemma and potassium-stimulated calcium uptake.

Authors:  V Flockerzi; R Mewes; P Ruth; F Hofmann
Journal:  Eur J Biochem       Date:  1983-09-01

10.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

View more
  3 in total

1.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Characterization of adenosine receptors in intact cultured heart cells.

Authors:  D el-Ani; K A Jacobson; A Shainberg
Journal:  Biochem Pharmacol       Date:  1994-08-17       Impact factor: 5.858

3.  Isolation and characterization of an avian A1 adenosine receptor gene and a related cDNA clone.

Authors:  J S Aguilar; F Tan; I Durand; R D Green
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.